Rett Syndrome, Rett Syndrome, Atypical, RTT
Conditions
Keywords
Biomarker, EEG, Evoked Potentials, MECP2
Brief summary
The goal of this observational study is to identify candidate biomarkers in individuals with Rett Syndrome (RTT). The main questions it aims to answer are: * Do these biomarkers change during clinical changes in individuals with RTT? * Are biomarkers stable over time in clinically stable individuals? * Do these biomarkers correlate with severity of RTT? Participants will be asked to undergo an electroencephalogram (EEG) with measurements of Evoked Potentials (EP) to measure electrical activity in the brain. Researchers will compare findings in individuals with RTT to those in typically developing individuals to see if there are differences between the two groups.
Detailed description
The main goal of the project is to identify potential biomarkers that can become measures for intervention and other translational studies and, at the same time, provide insight into abnormal synaptic activity and pathogenesis of RTT. Therefore, the proposed assessments will be performed with females with RTT and age matched typically developing females. These electrophysiological assessments will be compared to established clinical outcome measures from previous work in the NIH funded Rett and Rett related disorders natural history study. The neurophysiological parameters for RTT will be correlated with each other and also to disease staging, overall clinical severity scores and through exploratory analyses with specific clinical features. The investigators will also be testing procedures to perform the recordings, electrode types and placement, and ways to reduce movement and artifact within the data to establish best practices.
Interventions
OTHEREEG and Auditory and Visual Evoked Potentials (AEP and VEP)
Through up to eight standardized sessions, participants will undergo AEP and VEP, as well as resting state EEG.
OTHERClinical assessment
Established clinical measures for RTT will be collected for RTT participants
Sponsors
National Institute of Neurological Disorders and Stroke (NINDS)
Vanderbilt University Medical Center
Children's Hospital of Philadelphia
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
1 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
1. Rett Group: Females ages 3-18 (inclusive) with a clinical diagnosis of RTT with a likely pathogenic or known pathogenic variant in MECP2. 2. Likely Rett Group: Females from 1 year to \< 5 years of age with MECP2 variant if regression has not yet occurred or child is within 6 months of last skill loss. 3. Typically developing (TD) Group: Females age matched to RTT population (1-18) with no developmental or cognitive concerns as assessed using the Child/Adult Behavioral Checklist, Survey of Well-Being of Young Children (\<5yo), or the Wide Range Achievement Test-4 (\>5 yo).
Exclusion criteria
Rett and Likely Rett Groups: 1. Presence of a duplication in MECP2 or any other identified pathogenic mutation in another gene. 2. Active medical conditions not typically found in RTT. Typically Developing Group: 1. Score below norms on the performance tests 2. Have a known neurological disorder (excluding migraine) 3. Being on neuroactive medications.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Auditory Evoked Potential (AEP) amplitude | 5 years | Amplitude of P1, P2 and N1 peaks (uV) |
| Visual Evoked Potential (VEP) amplitude | 5 years | N1-P1 amplitude at Oz and other occipital electrodes will be calculated. |
| EEG Analysis | 5 years | EEG Root mean square (RMS) amplitude, Amplitude variability, 1/f constant, power bands in typical bands (Delta, theta, alpha, Beta, gamma) and ratios will be calculated. |
| Auditory Evoked Potential (AEP) latency (ms) | 5 years | Calculated N1, P1 latencies in Cz and other electrodes \[posterior temporal region (T5/P3/T3) electrodes\], will be used for analysis. |
| Visual Evoked Potential (VEP) latencies (ms) | 5 years | The latencies of the N1, P1, and N2 components will be identified primarily at occipital electrodes with Oz will be the primary electrode of analysis. N1-P1 time will be analyzed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| VEP spectral analysis, dipole determination and spatial distribution | 5 years | spectral analysis of the individual waveforms, dipole determination of N1 and P1 peaks and spatial distribution of peak values. |
| AEP spectral analysis, dipole determination and spatial distribution | 5 years | spectral analysis of the individual waveforms, dipole determination of N1 and P1 peaks and spatial distribution of peak values. |
Countries
United States
Contacts
Primary ContactHolly Dubbs, MS. CGC
Outcome results
None listed